HomeHomeForgotten Password?Register Now   Site MapAdvertising
THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET Advanced Search
This channel: Ingredients  >       
 
Most popular article in Biotechnology  
Ingredients
BioDuro, LLC Announces Appointment of Steven M. Hutchins as Vice President, Business Development & C...
 
Company:BioDuro, LLC
Date Published:02/08/2007
Articles in
Biotechnology:		 Select to view sub-categories of this category
 
 SubjectContributorDate Published
A MOLECULAR IDENTITY CRISIS - A "RIBOZYME WITHOUT RNA"



PR&D - Public Relations for Research and Education03/11/2008
GLAXOSMITHKLINE AND AFFIRIS SIGN AN EXCLUSIVE LICENCE AND OPTION AGREEMENT FOR THERAPEUTIC ALZHEIMER'S DISEASE CANDIDATE VACCINES



PR&D - Public Relations for Research and Education24/10/2008
AFFiRiS - MIG-FONDS INCREASES INVESTMENT BY EURO 3 MILLION



PR&D - Public Relations for Research and Education26/09/2008
Movianto Supports Pinnacle Biologics' Market Entry Into Europe



Movianto GmbH04/09/2008
Peakdale Molecular Launches Assayready4u(TM) In Collaboration With ChemPrintCo LLC



Peakdale Molecular Ltd27/08/2008
EXTREME COMPETITIVE SPORTS - A FITNESS TEST FOR DNA



PR&D - Public Relations for Research and Education21/08/2008
Immunovaccine Technologies congratulates Dr. Ramila Philip as one of PA's best 50 women in business



ImmunoVaccine Technologies Inc23/05/2008
Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim



Rentschler Biotechnologie21/05/2008
RPS Enhances Clinical Expertise And Leadership With Two Additions To Senior Management Team



ReSearch Pharmaceutical Services, Inc14/05/2008
New data support routine childhood vaccination with Prevenar in Europe



Wyeth14/05/2008
Finesse Solutions introduces the Truviu(TM) PLSS system



Finesse Solutions, LLC02/05/2008
Jonas Ohlsson appointed CEO/President of Cellectricon



Cellectricon AB30/04/2008
More Clinical Data Required To Support European Approval Of Cap Indication For TYGACIL



Wyeth Pharmaceuticals23/04/2008
Dosing for RVX-208 Phase 1A clinical study completed



Resverlogix Corp.22/04/2008
Raptor Pharmaceuticals Corp. initiates Phase IIA clinical study for Convivia(TM)



Raptor Pharmaceuticals21/04/2008
Finnish Biotech Company Sets World Record By Detecting 50 Dangerous Bacteria With Single Test In Quest To Battle Sepsis



Mobidiag Ltd21/04/2008
Elan to present at the Morgan Stanley global healthcare unplugged conference and host company day



Elan Corporation, plc18/04/2008
Worldwide pharmaceutical industry launches global health progress initiative to expand efforts to improve health in developing countries



Global Health Progress16/04/2008
Recent siRNA research publications support silence therapeutics combined development approach



Silence Therapeutics Plc07/04/2008
Dr. Ari Kiev To Address Biotechnology Conference, Wall Street Unplugged: The Trout Group Investor Seminar, In Munich April 7



SPRI Clinical Trials07/04/2008
 
 
First Previous 1 to 20 of 839 Next Last
  
   
 
© CMP information Ltd 2007
Terms and Conditions  Privacy Policy